NCT01101165View on ClinicalTrials.gov

To Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2007

Study Completion Date

July 31, 2007

Conditions
Healthy
Interventions
DRUG

Reformulated OXY (oxycodone HCl)

Reformulated OXY 40-mg tablet x 1 dose taken without food

DRUG

Original OxyContin® (OXY) (oxycodone HCl)

Original OxyContin® (OXY) 40-mg tablet x 1 dose taken without food

Trial Locations (1)

47714

Covance Clinical Research Unit - Evansville, Evansville

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT01101165 - To Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets | Biotech Hunter | Biotech Hunter